Physician profile
Joseph Gira
NPI 1861481152
$174,354.94
in general payments reported to CMS, 2019-2025
50 companies · $23K in 2025
The $23K reported for 2025 was more than what 97% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $31K · 2020: $6,963 · 2021: $21K · 2022: $61K · 2023: $13K · 2024: $18K · 2025: $23K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $23K · Consulting Fee: $20K · Long Term Medical Supply Or Device Loan: $7,475 · Travel and Lodging: $3,835 · Entertainment: $124 · Education: $17.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $22,748.06 |
| Consulting Fee | $20,152.83 |
| Long Term Medical Supply Or Device Loan | $7,474.85 |
| Travel and Lodging | $3,834.66 |
| Entertainment | $124.30 |
| Education | $17.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Beaver-Visitec International, INC. | $26,911.10 | 2022-2025 | |
| Optos, INC. | $26,410.53 | 2022-2024 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Glaukos Corporation | $23,713.20 | 2019-2025 | Epioxa, Travoprost Intraocular Implant - Idose, Idose Tr |
| Kala Pharmaceuticals, INC. | $13,830.78 | 2019-2022 | |
| Alcon Vision LLC | $9,368.24 | 2019-2025 | Hydrus Microstent, Clareon Panoptix Pro, Clareon |
| Sun Pharmaceutical Industries INC. | $7,657.94 | 2019-2025 | Cequa |
| Bausch & Lomb Americas INC. | $7,179.54 | 2022-2025 | Miebo, Envista Mx60 Iol, Stellaris Elite |
| Johnson & Johnson Surgical Vision, INC. | $6,940.14 | 2019-2025 | Tecnis Iol, Tecnis Simplicity, Tecnis Iol |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $6,552.45 | 2019-2021 | |
| Carl Zeiss Meditec, INC. | $4,430.18 | 2019-2024 | Iolmaster 700 |
| Allergan, INC. | $3,873.80 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $3,586.60 | 2019-2023 | |
| Carl Zeiss Meditec USA, INC. | $3,512.26 | 2021-2025 | Veracity Surgical, Visumax, Cirrus Hd-Oct |
| Biotissue Holdings INC. | $3,264.68 | 2019-2024 | |
| Eyevance Pharmaceuticals LLC | $3,048.45 | 2019-2023 | Flarex |
Show all 49 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tarsus Pharmaceuticals, INC. | $2,720.32 | 2024-2025 | Xdemvy |
| Ivantis, INC | $2,593.37 | 2019-2021 | |
| Harrow Eye, LLC | $2,414.58 | 2023-2025 | Iheezo, Triesence, Flarex |
| Bausch Health US, LLC | $2,400.00 | 2019-2021 | |
| Sight Sciences, INC. | $2,289.91 | 2019-2025 | Omni Surgical System, Sion Surgical Instrument |
| Abbvie INC. | $1,751.25 | 2022-2025 | |
| Lensar, INC. | $1,737.36 | 2022-2023 | Lensar Laser System |
| Eyepoint US, INC. | $1,492.55 | 2019-2021 | |
| Shire North American Group INC | $1,435.80 | 2019 | |
| Rxsight INC | $1,021.15 | 2022-2025 | Rxsight Injector Handpiece, Rxsight Light Delivery Device (Ldd), Rxsight Injector Cartridge |
| Ocular Therapeutix, INC. | $950.94 | 2019-2025 | Dextenza |
| New World Medical,INC. | $354.82 | 2019-2025 | Ahmed Glaucoma Valve, Kahook Dual Blade, Clearpath |
| Omeros Corporation | $302.61 | 2019-2021 | |
| Horizon Therapeutics Plc | $262.15 | 2021-2023 | Tepezza |
| The Cameron-Ehlen Group, INC. | $248.51 | 2020-2021 | |
| Rayner Intraocular Lenses Limited | $243.54 | 2023-2025 | Rayone Spheric, Rayone Aspheric, Rayone Emv |
| Dompe US, INC. | $209.63 | 2022-2025 | Oxervate |
| Aerie Pharmaceuticals, INC. | $208.41 | 2019-2020 | |
| Merz Pharmaceuticals, LLC | $165.55 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $162.77 | 2021-2023 | Eylea |
| Oyster Point Pharma, INC. | $144.87 | 2022-2025 | Tyrvaya |
| Haag-Streit USA, INC. | $144.71 | 2024 | |
| Topcon Healthcare Solutions, INC. | $117.47 | 2021-2022 | |
| Apellis Pharmaceuticals, INC. | $110.29 | 2022 | |
| Integra Lifesciences Corporation | $93.83 | 2020 | |
| Tearlab Corp | $92.90 | 2019-2023 | Tearlab Osmolarity System |
| Staar Surgical Company | $79.97 | 2019 | |
| Coopervision INC. | $76.52 | 2024 | Myday Contact Lens |
| Amgen INC. | $73.33 | 2024-2025 | Tepezza |
| Leica Microsystems INC. | $61.00 | 2024 | Surgical Microscopes |
| Ani Pharmaceuticals, INC. | $49.60 | 2025 | Purified Cortrophin Gel |
| Lkc Technologies, INC. | $28.54 | 2025 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Biogen, INC. | $17.40 | 2023 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$405,160.03 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Gira listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.